Gara Jalqabaatti › Dukkana Dhiigaa › Colorado › Denver
Qorannoo klinikaalii Dukkana Dhiigaa Denver, CO keessatti
Qorannoo 9 Dukkana Dhiigaa f Denver fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
Namoota walitti qabaa jiraSadarkaa 2
- Colorado Blood Cancer Institute ( Site 2726), Denver
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- AdventHealth Porter, Denver
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
Namoota walitti qabaa jiraSadarkaa 3
- CBCI, Colorado Blood Cancer Institute, Denver
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Namoota walitti qabaa jiraSadarkaa 3
- Colorado Blood Cancer Institute, Denver
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
- Colorado Blood Cancer Institute, Denver
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Colorado Blood Cancer Institute, Denver
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Namoota walitti qabaa jiraSadarkaa 1
- Colorado Blood Cancer Institute, Denver
Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- Children's Hospital Colorado, Denver
Qorannoo Dukkana Dhiigaa magaalota biroo keessatti
- Houston, TXQorannoo 46
- New York City, NYQorannoo 26
- Boston, MAQorannoo 25
- Washington, DCQorannoo 19
- Seattle, WAQorannoo 18
- Baltimore, MDQorannoo 18
- Los Angeles, CAQorannoo 17
- Durham, NCQorannoo 16
- Chicago, ILQorannoo 15
- Philadelphia, PAQorannoo 14
- Columbus, OHQorannoo 13
- Edison, NJQorannoo 13
Qorannoo biroo Denver keessatti
- Kansara MetastatikiiQorannoo 29
- Saree OljooQorannoo 29
- Kansara Qara'a Non-Small CellQorannoo 27
- Myeloma Baay’eeQorannoo 27
- Kansarii ColorectalQorannoo 23
- MelanomaQorannoo 19
- Kansarii ProstateQorannoo 19
- Saree (Gosoota Hunda)Qorannoo 18
- Kansarii OvariiQorannoo 16
- Dhibee QaraQorannoo 16
- Kansa EndometiriyaaliiQorannoo 15
- Non-Hodgkin LymphomaQorannoo 14
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.